The Real Profiteers in Healthcare Aren’t Drugmakers

DC JOURNAL

Pressure is building on Capitol Hill for Congress to codify President Trump’s “most favored nation” drug-pricing initiative into law.

The administration has already struck deals with more than a dozen drugmakers to sell medicines to Medicaid, the federal-state health plan for low-income individuals and the disabled, at the lowest prices paid by other developed nations. Now lawmakers are debating whether to impose the same framework across the U.S. market.

The effort is premised on a familiar claim — that pharmaceutical companies are reaping outsized profits at patients’ expense. The data tell a very different story.

In fact, drug manufacturers are among the least profitable players in the healthcare system.

Read more here.